期刊
ONCOTARGETS AND THERAPY
卷 8, 期 -, 页码 3783-3792出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/OTT.S95470
关键词
CD44; epithelial-mesenchymal transition; tumor progression; prognosis
资金
- National Natural Science Foundation of China [81572608, 81172422, 81072169]
- [R01CA132115-05A1]
CD44, a multi-structural and multifunctional transmembrane glycoprotein, was initially identified as a receptor for hyaluronan that participates in both physiological and pathological processes. CD44 is found to be closely linked to the development of various solid tumors. Molecular studies have revealed that high CD44 expression was correlated with the phenotypes of cancer stem cells and epithelial-mesenchymal transition, thereby contributing to tumor invasion, metastasis, recurrence, and chemoresistance. Correspondingly, blockade of CD44 has been demonstrated to be capable of attenuating the malignant phenotype, slowing cancer progression, and reversing therapy resistance. Clinical analyses showed that high CD44 expression is associated with poor survival of various cancer patients, indicating that CD44 can be a potential prognostic marker. In this review, we summarize recent research progress of CD44 on tumor biology and the clinical significance of CD44.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据